A look at a company announcement about a new plant‑based botanical ingredient for supporting women through perimenopause and menopause. It previews a clinical study–backed product aimed at multi-symptom midlife wellness and formulation use.
Key Takeaways
- 09:35 ET Share this article A clinically backed
- Fenavari was shown to support seven key concerns associated with midlife hormonal changes
- OmniActive's proprietary research with nearly 500 women ages 45+ found that 61% experience hot flashes